Oral Session 1 July 4 2:00pm - 5:00pm 6 speakers
Chairperson: Junho Chung, M.D., Ph.D., Seoul National University
2:00pm - 2:25pm
PharmAbcine's bispecific antibodies and its innovation
Jin-San Yoo, Dr. rer. Nat, PharmAbcine, Inc.
2:25pm - 2:50pm
CD80/IL2v dual checkpoint inhibitor for solid tumors
Myoung Ho Jang, Ph.D., GI Innovation Inc.
2:50pm - 3:15pm
Cancer immunotherapy targeting TNF receptor superfamily
Hyun-Bae Jie, Ph.D., Ambrx
3:15pm - 3:45pm
Coffee Break & Poster Viewing
3:45pm - 4:10pm
Double immune check point antibodies for cancer immunotherapy
Young-Gyu Cho, Ph.D., Y-Biologics Inc.
4:10pm - 4:35pm
A novel mucosal vaccine leads to longevity with beneficial health effects
Kyung A Cho, Ph.D., Chonnam National University Medical School
4:35pm - 5:00pm
Therapeutic effects of novel Tau antibody for Alzheimer’s disease
Seung-Yong Yoon, M.D., Ph.D., University of Ulsan College of Medicine